Next Biomedical Co.,Ltd. (KOSDAQ:389650)

South Korea flag South Korea · Delayed Price · Currency is KRW
66,100
+1,700 (2.64%)
Last updated: Nov 20, 2025, 12:42 PM KST
2.64%
Market Cap528.33B
Revenue (ttm)12.16B
Net Income (ttm)2.57B
Shares Out8.20M
EPS (ttm)-273.00
PE Ratio205.23
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume79,190
Average Volume105,037
Open65,000
Previous Close64,400
Day's Range64,300 - 67,900
52-Week Range27,250 - 86,500
Betan/a
RSI52.88
Earnings Daten/a

About Next Biomedical

Next Biomedical Co.,Ltd. engages in the research and development, production, and development of therapeutics, drug delivery system and drug-medical device products in South Korea. It offers hemostatic material for endoscope; and microspheres for vascular embolization. The company was founded in 2014 and is based in Incheon, South Korea. [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2014
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 389650
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.